Persistence mechanisms in Pseudomonas aeruginosa from cystic fibrosis patients undergoing ciprofloxacin therapy.
about
Response mechanisms of bacterial degraders to environmental contaminants on the level of cell walls and cytoplasmic membraneDevelopment of multiple-antibiotic-resistant (Mar) mutants of Pseudomonas aeruginosa after serial exposure to fluoroquinolones.Purification of a 54-kilodalton protein (OprJ) produced in NfxB mutants of Pseudomonas aeruginosa and production of a monoclonal antibody specific to OprJCiprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureusNucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori.nfxC-type quinolone resistance in a clinical isolate of Pseudomonas aeruginosa.Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients.Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates.Quinolone resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during therapy and clinical significance.
P2860
Q27012745-571FEAEC-E759-4576-996A-4A823564A6F2Q35111809-745FF30D-45EB-40B3-9961-5D87089174EDQ35117101-8A2EBE17-CE9C-4A8C-A71D-951F273B28C5Q35816058-C9DD69EB-AB60-4C83-A37D-E528D11733E1Q39778896-DBD2275A-550C-4A3B-BBF3-EBEFA8B95AB3Q39779448-A26A84E5-DB07-4A19-8E2B-386B1BE0360CQ40188725-4D4FE58A-A5CB-4753-9645-424867349B7AQ40286229-E3F69516-CF7A-4C3E-8AF2-2973A7BB6C73Q40633555-0799FCDC-3143-4986-99C4-1A4F09578794
P2860
Persistence mechanisms in Pseudomonas aeruginosa from cystic fibrosis patients undergoing ciprofloxacin therapy.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Persistence mechanisms in Pseu ...... ergoing ciprofloxacin therapy.
@en
type
label
Persistence mechanisms in Pseu ...... ergoing ciprofloxacin therapy.
@en
prefLabel
Persistence mechanisms in Pseu ...... ergoing ciprofloxacin therapy.
@en
P2093
P2860
P356
P1476
Persistence mechanisms in Pseu ...... ergoing ciprofloxacin therapy.
@en
P2093
P2860
P304
P356
10.1128/AAC.35.8.1538
P407
P577
1991-08-01T00:00:00Z